Clinical Trial Update: Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update on safety and efficacy of Exjade for transfusion-dependent iron overload in patients with aplastic anemia; study terminated with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Exjade (deferasirox)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Aplastic Anemia | Phase 4 | Status: TERMINATED | Results posted: 2019-08-16